Positron Emission Tomography with 18F-Fluorodeoxyglucose of Uterine Sarcoma: A Comparison with Magnetic Resonance Imaging and Power Doppler Imaging
- 31 March 2001
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 80 (3), 372-377
- https://doi.org/10.1006/gyno.2000.6081
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Uterine sarcoma: can it be differentiated from uterine leiomyoma with Doppler ultrasonography? A preliminary reportUltrasound in Obstetrics & Gynecology, 1997
- Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Positron emission tomography in oncology: General acceptance of its role is overdueCancer, 1996
- Uterine Sarcoma: A Report of 10 Cases Studied by Transvaginal Color and Pulsed Doppler SonographyGynecologic Oncology, 1995
- Assessment of Primary and Metastatic Ovarian Cancer by Positron Emission Tomography (PET) Using 2-[18F]Deoxyglucose (2-[18F]FDG)Gynecologic Oncology, 1993
- Cancer Detection with Whole-Body PET Using 2-[18F]Fluoro-2-Deoxy-D-GlucoseJournal of Computer Assisted Tomography, 1993
- Leiomyosarcomas: Clinical presentationAmerican Journal of Obstetrics and Gynecology, 1993
- Leiomyosarcoma of the Uterus: Ultrasonography and Serum Lactate Dehydrogenase LevelGynecologic and Obstetric Investigation, 1992
- CA-125:Use as a tumor marker with mixed mesodermal tumors of the female genital tractCancer, 1986